Legacy Advisors’s Sanofi SNY Stock Holding History

Legacy Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-32	Closed	-$1K	–	452
2018 Q1	$1K	Buy	+32	New	+$1.33K	﹤0.01%	371
2017 Q4	–	Sell	-116	Closed	-$5K	–	418
2017 Q3	$5K	Buy	+116	New	+$5.61K	0.01%	294

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Legacy Advisors's SNY Position: Q2 2018 in Review

Legacy Advisors sold out of Sanofi (SNY) in Q2 2018, closing a stake of 32 shares — an estimated $1K sold.

Legacy Advisors first reported a position in SNY in Q3 2017 and held it in 2 quarters. The position peaked at $5K in Q3 2017. 478 funds tracked by Wall St. Rank hold SNY as of Q2 2018.

Legacy Advisors reported no remaining Sanofi position as of Q2 2018 after selling out during the quarter.
Legacy Advisors sold 32 Sanofi shares in Q2 2018, an estimated $1K.
Legacy Advisors first reported a position in Sanofi in Q3 2017 and held it in 2 quarters.
Legacy Advisors's Sanofi position peaked at $5K in Q3 2017.
478 funds tracked by Wall St. Rank held Sanofi as of Q2 2018.

Based on Legacy Advisors's 13F filing for Q2 2018, filed 19 Jul 2018.